Clinical Trials Search at Vanderbilt-Ingram Cancer Center

CY 6022 - A FOLLOW-UP, OPEN-LABEL, RESEARCH EVALUATION OF SUSTAINED TREATMENT WITH AFICAMTEN (CK-3773274) IN HYPERTROPHIC CARDIOMYOPATHY (HCM)

Disease Sites:

Not Available

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Brinkley, Douglas

Participating Institutions:

Vanderbilt University

Open Date:

11-30-2022

Trial Type:

Other

Protocol ID:

CRE-CHF0014

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available